EUVIMEDEUVIMED entdecken
Crossref

SherpaPak Cardiac Transport System: Experience in Pediatric Heart Transplantation

Anna Sather, Molly Marshall, Raghav Murthy, Jacqueline M Lamour, Christyn Chase, Neha Bansal iD

Clinical Transplantation · 2025-02 · 39 (2)

DOI: 10.1111/ctr.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 30.01.2025. Verfasst von Anna Sather und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Defects, Congenital, Organ Preservation, Tissue Donors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The present study aimed to assess the clinical outcomes of pediatric heart transplant patients whose donor hearts were preserved with the SherpaPakCardiac Transport System.

Methods

All pediatric patients undergoing heart transplantation at our center between January 2020 and June 2024 were included and described. Vasoactive inotropic score (VIS) was calculated. The cohort was divided into two groups by recipient diagnoses (cardiomyopathy vs. congenital heart disease [CHD]). They were compared based on demographics, operative details, and postoperative outcomes. The χ 2 and Fisher exact tests were used for categorical variables and the Mann–Whitney U test or t ‐test for continuous variables.

Results

A total of 18 patients were included. The median recipient age was 11.9 years (IQR: 2.5, 13.9). Half had cardiomyopathy, median total ischemic time was 236 min (IQR: 211.5, 283.5). Upon comparing the two groups, there were no significant differences observed in VIS or primary graft dysfunction (PGD) even though the median circulatory arrest time and bypass times were significantly longer in the CHD group ( p < 0.05). Three patients experienced early rejection (all with CHD), but there was no mortality.

Conclusions

The SherpaPak Cardiac Transport System provides safe outcomes for pediatric heart transplant patients, including those with complex CHD. Further multi‐institutional and registry studies are needed to evaluate this method for pediatric heart transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart Defects, CongenitalOrgan PreservationTissue DonorsGraft RejectionPostoperative ComplicationsCardiomyopathiesHumansChildFemaleMaleFollow-Up StudiesAdolescentPrognosisRetrospective StudiesChild, PreschoolGraft SurvivalRisk FactorsInfant

Stichwörter der Autor:innen

donors and donationheart (allograft) function/dysfunctionheart disease: congenital

Autor:innen und Institutionen

  • Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Pediatric Cardiology, Mount Sinai Kravis Children's Hospital, New York, New York, USA.
  • Pediatric Cardiovascular Surgery, Mount Sinai Kravis Children's Hospital, New York, New York, USA.

ORCID-Profile: Neha Bansal

Zitieren

APA

Sather, A., Marshall, M., Murthy, R., Lamour, J. M., Chase, C., & Bansal, N. (2025). SherpaPak Cardiac Transport System: Experience in Pediatric Heart Transplantation. Clinical Transplantation, 39(2). https://doi.org/10.1111/ctr.70095

Vancouver

Sather A, Marshall M, Murthy R, Lamour JM, Chase C, Bansal N. SherpaPak Cardiac Transport System: Experience in Pediatric Heart Transplantation. Clinical Transplantation. 2025;39(2). doi:10.1111/ctr.70095

BibTeX
@article{Sather2025,
  author = {Sather, Anna and Marshall, Molly and Murthy, Raghav and Lamour, Jacqueline M and Chase, Christyn and Bansal, Neha},
  title = {SherpaPak Cardiac Transport System: Experience in Pediatric Heart Transplantation},
  journal = {Clinical Transplantation},
  year = {2025},
  volume = {39},
  number = {2},
  doi = {10.1111/ctr.70095}
}
Kostenlos starten →